top of page

ILDONG Bioscience's "RHT3201" FDA Registration in Thailand

2024년 4월 11일

Registering "RHT3201" in Thailand: A Milestone for Functional Food Advancements

Ildong Bioscience, a subsidiary of the Ildong Pharmaceutical Group specializing in health functional foods, has recently announced the registration of its functional postbiotic "RHT3201" with the Thai Food and Drug Administration (Thai FDA) on April 11th.

"RHT3201" is a postbiotic developed from a non-viable form of the probiotic strain, specifically processed from a probiotic akin to Lactobacillus rhamnosus IDCC 3201. It's utilized as a key ingredient in functional products aimed at enhancing skin immunity.

The successful registration of "RHT3201" as a Thai FDA-approved food ingredient signifies Ildong Bioscience's achievement in proving the product's quality and safety. It also establishes a strong foothold for the company in the Thai market.

Ildong Bioscience is exploring opportunities to supply finished products to Thai businesses using Original Design Manufacturing (ODM) methods alongside its existing raw material supply operations.

Moreover, the company aims to broaden its scope by registering various other functional ingredients and substances it possesses, including different types of probiotics and postbiotics, further enriching its product portfolio.

Ildong Bioscience has a history of engagement with the Thai market, primarily through the export of probiotic raw materials. Notably, their ODM products distributed to Thai partners last year gained significant acclaim, being recognized as top sellers in the probiotics category by prominent local pharmacies.

The company's strategy revolves around leveraging its in-depth knowledge and technical capabilities in probiotics and postbiotics, as well as its advanced manufacturing processes, such as the quadruple coating technique. This approach, combined with region-specific marketing strategies, aims to enhance its market presence in Thailand.

Ildong Bioscience was established in 2016 under Ildong Holdings, drawing upon Ildong Pharmaceutical's extensive experience and technological background in probiotics. Today, the company is actively engaged in the development of functional materials and products utilizing probiotics, alongside its raw material supply and OEM/ODM business ventures.

Your Questions, Our Answers

Curious about our latest news? Have specific inquiries following our recent updates? ILDONG Bioscience is here to responses!

bottom of page